Maximize Your Impact At Oncology Venture, Innovation & Partnering Summit 2025
The Oncology Venture, Innovation & Partnering Summit 2025, taking place on September 29, brings together senior biotech executives, oncology-focused investors, and international pharma leaders at the Westin Boston Seaport in Boston, Massachusetts. As one of the few events fully focused on oncology deal-making and R&D collaboration, this summit is known for facilitating high-value partnerships and licensing discussions across early discovery through late-stage clinical development.
This event attracts decision-makers from biotech companies actively developing oncology assets, as well as large pharmaceutical companies looking to expand their pipelines via external innovation. Attendees are often involved in evaluating funding opportunities, tech partnerships, and co-development deals. The summit creates timely, commercially relevant conversations around program funding, long-term strategy, and organizational alignment. Having access to the enriched attendee list allows commercial teams to identify cross-functional decision makers—spanning BD, clinical, and strategy roles—and prioritize outreach with precision ahead of the event.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Sales and marketing teams that support biopharma commercialization, clinical operations, or enablement tools can use the enriched attendee list to get closer to their target accounts—well before the event begins. Oncology biotech companies are often lean, with key leadership serving multiple roles across research and business. Engaging early ensures your message connects with the person that drives partner selection, product evaluation, and licensing negotiation.
Use attendee data to segment based on development stage or asset focus—such as immunotherapy, cell therapy, or targeted oncology. Customize your messaging around the company’s therapeutic pipeline and clinical priorities. With email and phone data, you can begin outreach well in advance to schedule meetings with high-value prospects attending the conference. On-site, use attendee insights to steer meaningful conversations that extend into long-term partnerships. Post-event, leverage the enriched contact info to follow up with tailored messaging connected to the strategic goals discussed during the summit. Knowing how to get more meetings depends on understanding who is attending—and that visibility starts with the Vendelux conference attendee list.
Timing Is Everything
Oncology Venture, Innovation & Partnering Summit 2025 takes place on September 29, 2025. With many attendees finalizing clinical partnerships and evaluating service providers for budget deployment in Q4 and beyond, early outreach can significantly increase your chances of securing investment or partnership discussions during the event.
Using Vendelux, your team gets early access to the attendee list—allowing you to align your outreach strategy with the event’s key stakeholders. Connecting ahead of time positions your solution at the forefront of ongoing decision-making and helps establish rapport before those critical 1:1 meetings happen onsite.
What’s Included In The Oncology Venture, Innovation & Partnering Summit 2025 Attendee List?
Vendelux provides insight into who’s expected to attend through a combination of organizer-supplied data and predictive analytics. You can upload your ABM list to immediately identify matching attendee profiles.
The enriched conference attendee list includes each contact’s first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, and verified email addresses. Where available, direct phone numbers are also provided.
Where Is Oncology Venture, Innovation & Partnering Summit 2025?
The event will be held at the Westin Boston Seaport in Boston, Massachusetts, United States.
When Is Oncology Venture, Innovation & Partnering Summit 2025?
This summit is scheduled for September 29, 2025.
What Type Of Event Is Oncology Venture, Innovation & Partnering Summit 2025?
This is a pharmaceutical and biotech partnering event centered on innovation in oncology. The program includes executive-level networking, fireside chats, company presentations, and panels focused on R&D pipelines, spinout science, venture funding, and licensing strategy. It serves as a productivity-focused gathering for decision-makers shaping the future of oncology treatment.
How Many People Attend Oncology Venture, Innovation & Partnering Summit 2025?
The event is expected to host more than 300 participants from across North America and Europe, including C-level executives, VPs of business development, scientists turned founders, venture-backed startups, and innovation leads from major pharmaceutical companies. Most attendees are senior leaders with significant decision-making responsibility spanning product development and strategic partnerships.
